Locally Advanced Lung Non-Small Cell Carcinoma
Oncology·MeSH: Lung Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| osimertinib | CG Oncology, Inc. (CGON) |
Frequently asked questions
How many drugs are in development for Locally Advanced Lung Non-Small Cell Carcinoma?
BioSniper tracks 1 drug in development for Locally Advanced Lung Non-Small Cell Carcinoma across 1 company.
How many clinical trials target Locally Advanced Lung Non-Small Cell Carcinoma?
There are 1 clinical trial targeting Locally Advanced Lung Non-Small Cell Carcinoma tracked by BioSniper.
Deep-dive into Locally Advanced Lung Non-Small Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis